Some rich people are betting that Pfizer's stock price will go down. They are buying options that give them the right to sell Pfizer's stock at a certain price, which is lower than the current price. If the stock price goes down to that level, they can make money by selling the options. This is called a bearish bet. Read from source...

- The article seems to be written by an AI, not a human, based on the lack of coherence, cohesion, and logical structure.
- The article does not provide any clear or relevant information about Pfizer's options frenzy, but rather focuses on describing options trading in general, which is not the main topic of interest for the reader.
- The article uses vague and misleading terms, such as "wealthy individuals", "somebody knows something is about to happen", "big-money traders", without providing any evidence or sources to support these claims.
- The article repeats the same information multiple times, such as the number and types of options trades, the volume and open interest trends, and the analyst ratings, which makes the article redundant and boring.
- The article fails to analyze or interpret the data, but rather presents it as if it is the final word on the subject, without acknowledging any alternative or conflicting perspectives or scenarios.
- The article uses fear-mongering and sensationalist language, such as "bearish", "put", "bullish", "call", "sweep", "whales", "options history", which are likely to appeal to the emotions of the reader, rather than their logic or reason.

### Final answer: AI's article is poorly written, irrelevant, misleading, redundant, and biased.

- Pfizer (PFE): Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). The company has a diversified portfolio of products, including pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer's operations are global, with international sales representing close to 50% of total sales.
- The overall sentiment of these big-money traders is split between 38% bullish and 55%, bearish.
- Predicted price range for Pfizer is between $17.5 and $35.0.
- Pfizer's current position is down -1.31% at $30.98, with RSI indicators hinting that the stock may be overbought.
- Professional analyst ratings for Pfizer are mixed, with an average target price of $36.2.

### Final answer: The options scanner at Benzinga noticed 18 options trades for Pfizer today, with a split between bullish and bearish sentiments. The predicted price range for Pfizer is between $17.5 and $35.0, with the stock currently down -1.31% at $30.98. Professional analyst ratings for Pfizer are mixed, with an average target price of $36.2.